We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Drug firm Eris Lifesciences has reported a 34.51 per cent rise in its consolidated net profit to Rs 93.14 crore for the second quarter ended September 30.